All Stories

  1. Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

    Article • Journal of Viral Hepatitis, October 2018, Wiley

    Professor Manuel Romero-Gómez, JUAN JOSE SANCHEZ

  2. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo, Dr Carmelo Garcia-Monzon , Dr Eduardo EVG Vilar Gomez

  3. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis

    Article • Liver International, May 2018, Wiley

    Professor Manuel Romero-Gómez, Chang-Hai Liu

  4. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

    Article • Hepatology Communications, May 2018, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo, Radan Bruha

  5. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

    Article • Journal of Gastroenterology and Hepatology, February 2018, Wiley

    Professor Manuel Romero-Gómez

  6. Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

    Article • Alimentary Pharmacology & Therapeutics, February 2018, Wiley

    Professor Manuel Romero-Gómez

  7. High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

    Article • Liver International, June 2017, Wiley

    Professor Valentín Cuervas-Mons, Professor Manuel Romero-Gómez, Javier Crespo, Vanessa Hontangas, JUAN JOSE SANCHEZ

  8. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry

    Article • Hepatology, April 2017, Wiley

    Professor Manuel Romero-Gómez, Javier Crespo

  9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients

    Article • Journal of Gastroenterology and Hepatology, September 2016, Wiley

    Professor Manuel Romero-Gómez

  10. Sofosbuvir modulates the intimate relationship between hepatitis C virus and lipids

    Article • Hepatology, January 2015, Wiley

    Professor Manuel Romero-Gómez